Research Papers

25 of 55 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nan…
Man F; Gawne PJ; T M de Rosales R.
Adv Drug Deliv Rev (Unknown)
Published: 2019
1/6 Transparent
Funding Declared
Aptamers: Uptake mechanisms and intracellular applications.
Yoon S; Rossi JJ.
Adv Drug Deliv Rev (Unknown)
Published: 2018
1/6 Transparent
Funding Declared
Advances in keratinocyte delivery in burn wound care.
Ter Horst B; Chouhan G; Moiemen NS; Grover LM.
Adv Drug Deliv Rev (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Biosensors based on graphene oxide and its biomedical application.
Lee J; Kim J; Kim S; Min DH.
Adv Drug Deliv Rev (Unknown)
Published: 2016
1/6 Transparent
Funding Declared
MicroRNAs in vascular tissue engineering and post-ischemic neovascularization.
Caputo M; Saif J; Rajakaruna C; Brooks M; Angelini GD; Emanueli C.
Adv Drug Deliv Rev (Unknown)
Published: 2015
1/6 Transparent
Funding Declared
Prediction of drug-ABC-transporter interaction--Recent advances and future challenges.
Montanari F; Ecker GF.
Adv Drug Deliv Rev (Unknown)
Published: 2015
1/6 Transparent
Funding Declared
Delivery of therapeutic oligonucleotides with cell penetrating peptides.
Boisguérin P; Deshayes S; Gait MJ; O'Donovan L; Godfrey C; Betts CA; Wood MJ; Lebleu B.
Adv Drug Deliv Rev (Unknown)
Published: 2015
1/6 Transparent
Funding Declared
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J.
Adv Drug Deliv Rev (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Biologics for tendon repair.
Docheva D; Müller SA; Majewski M; Evans CH.
Adv Drug Deliv Rev (Unknown)
Published: 2014
1/6 Transparent
Funding Declared
Gene and cell therapy for children--new medicines, new challenges?
Buckland KF; Bobby Gaspar H.
Adv Drug Deliv Rev (Unknown)
Published: 2014
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.
Barker CI; Germovsek E; Hoare RL; Lestner JM; Lewis J; Standing JF.
Adv Drug Deliv Rev (Unknown)
Published: 2014
1/6 Transparent
Funding Declared
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.
Andrade F; Rafael D; Videira M; Ferreira D; Sosnik A; Sarmento B.
Adv Drug Deliv Rev (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Chitosans for delivery of nucleic acids.
Buschmann MD; Merzouki A; Lavertu M; Thibault M; Jean M; Darras V.
Adv Drug Deliv Rev (Unknown)
Published: 2013
Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.
Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM.
Adv Drug Deliv Rev (Unknown)
Published: 2012
1/6 Transparent
Funding Declared
Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.
Plank C; Zelphati O; Mykhaylyk O.
Adv Drug Deliv Rev (Unknown)
Published: 2011
1/6 Transparent
Funding Declared
Intestinal lymphatic transport for drug delivery.
Yáñez JA; Wang SW; Knemeyer IW; Wirth MA; Alton KB.
Adv Drug Deliv Rev (Unknown)
Published: 2011
Pulmonary delivery of therapeutic siRNA.
Lam JK; Liang W; Chan HK.
Adv Drug Deliv Rev (Unknown)
Published: 2011
1/6 Transparent
Funding Declared
DNA nanomedicine: Engineering DNA as a polymer for therapeutic and diagnostic applications.
Campolongo MJ; Tan SJ; Xu J; Luo D.
Adv Drug Deliv Rev (Unknown)
Published: 2010
Nanobioimaging and sensing of infectious diseases.
Tallury P; Malhotra A; Byrne LM; Santra S.
Adv Drug Deliv Rev (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Extracellular barriers in respiratory gene therapy.
Sanders N; Rudolph C; Braeckmans K; De Smedt SC; Demeester J.
Adv Drug Deliv Rev (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Nanotechnology in vaccine delivery.
Peek LJ; Middaugh CR; Berkland C.
Adv Drug Deliv Rev (Unknown)
Published: 2008
Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
Trevaskis NL; Charman WN; Porter CJ.
Adv Drug Deliv Rev (Unknown)
Published: 2007
Cell penetrating peptide conjugates of steric block oligonucleotides.
Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ.
Adv Drug Deliv Rev (Unknown)
Published: 2007
1/6 Transparent
Funding Declared
Modulation of host metabolism as a target of new antivirals.
Ikeda M; Kato N.
Adv Drug Deliv Rev (Unknown)
Published: 2007
"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
Medina-Kauwe LK.
Adv Drug Deliv Rev (Unknown)
Published: 2007
1/6 Transparent
Funding Declared